尿激酶、抵克力得治疗老年人高黏血症的对比研究

摘要

为比较尿激酶、抵克力得对高黏血症的治疗作用，将46例老年患者分为尿激酶(24例)、抵克力得(22例)2组。尿激酶组静脉给尿激酶25万 U/d，10 d为1个疗程，抵克力得组口服抵克力得0.25 g/d，20 d为1个疗程。分别于单个疗程前后检测血液流变学指标。结果：2组血液黏度均下降，但作用环节不同。提示：2种药物均可治疗老年人高黏血症，并宜根据具体血液流变学指标合理选药。%To determine the effects of urokinase and ticlopidine on blood viscosity parameters in the elderly patients. Fouty-six patients were randomly divided into two groups. Twenty-four patients were treated by vein with urokinase at dose of 250 000 U/d, 22 patients were treated with ticlopidine at dose of 0.25 g/d. And blood viscosity paramoters were measured. Both urokinase and ticlopidine could decrease blood viscosity, but have different effect on blood viscosity parameters. The two drugs have different effects on treating blood hyperviscosity. They should be used according to blood viscosity parameters.